{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:02:15Z","timestamp":1781010135251,"version":"3.54.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T00:00:00Z","timestamp":1219968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Urban Health"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s11524-008-9312-9","type":"journal-article","created":{"date-parts":[[2008,8,28]],"date-time":"2008-08-28T16:12:12Z","timestamp":1219939932000},"page":"812-825","source":"Crossref","is-referenced-by-count":46,"title":["The North American Opiate Medication Initiative (NAOMI): Profile of Participants in North America\u2019s First Trial of Heroin-Assisted Treatment"],"prefix":"10.1007","volume":"85","author":[{"given":"Eugenia","family":"Oviedo-Joekes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohdan","family":"Nosyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Brissette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Chettiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Schneeberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Krausz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aslam","family":"Anis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin T.","family":"Schechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,8,29]]},"reference":[{"key":"9312_CR1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(98)05356-2","volume":"353","author":"J Ward","year":"1999","unstructured":"Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet. 1999;353:221\u2013226.","journal-title":"Lancet"},{"key":"9312_CR2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/070674370605101003","volume":"51","author":"W Brink Van den","year":"2006","unstructured":"Van den Brink W, Haasen C. Evidenced-based treatment of opioid-dependent patients. Can J Psychiatry. 2006;51:635\u2013646.","journal-title":"Can J Psychiatry"},{"key":"9312_CR3","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","volume":"284","author":"AT McLellan","year":"2000","unstructured":"McLellan AT, Lewis DC, O\u2019Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284:1689\u20131695.","journal-title":"JAMA"},{"key":"9312_CR4","unstructured":"Single E, A sociodemographic profile of drug users in Canada. Ontario, Canada: HIV\/AIDS prevention and community action programs of Health Canada. 2000."},{"key":"9312_CR5","unstructured":"Federal patacoph. Reducing the harm associated with injection drug use in Canada. Ottawa: Federal, provincial and territorial advisory committee on population health. 2001."},{"key":"9312_CR6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.puhe.2005.09.010","volume":"120","author":"S Popova","year":"2006","unstructured":"Popova S, Rehm J, Fischer B. An overview of illegal opioid use and health services utilization in Canada. Public Health. 2006;120:320\u2013328.","journal-title":"Public Health"},{"key":"9312_CR7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.drugalcdep.2003.10.012","volume":"73","author":"B Brands","year":"2004","unstructured":"Brands B, Blake J, Sproule B, Gourlay D, Busto U. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend. 2004;73:199\u2013207.","journal-title":"Drug Alcohol Depend"},{"key":"9312_CR8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/jurban\/jti049","volume":"82","author":"B Fischer","year":"2005","unstructured":"Fischer B, Rehm J, Brissette S, et al. Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). J Urban Health. 2005;82:250\u2013266.","journal-title":"J Urban Health"},{"key":"9312_CR9","unstructured":"CHASE Project Team. Community Health And Safety Evaluation (CHASE). 2005. Vancouver Coastal Health Authority."},{"key":"9312_CR10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugalcdep.2005.11.011","volume":"83","author":"MW Tyndall","year":"2006","unstructured":"Tyndall MW, Kerr T, Zhang R, King E, Montaner JG, Wood E. Attendance, drug use patterns, and referrals made from North America\u2019s first supervised injection facility. Drug Alcohol Depend. 2006;83:193\u2013198.","journal-title":"Drug Alcohol Depend"},{"key":"9312_CR11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11524-007-9225-z","volume":"85","author":"P De","year":"2008","unstructured":"De P, Cox J, Boivin JF, Platt RW, Jolly AM. Social network-related risk factors for bloodborne virus infections among injection drug users receiving syringes through secondary exchange. J Urban Health. 2008;85:77\u201389.","journal-title":"J Urban Health"},{"key":"9312_CR12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jurban\/jth148","volume":"81","author":"LM Kuyper","year":"2004","unstructured":"Kuyper LM, Hogg RS, Montaner JSG, Schechter MT, Wood E. The cost of inaction on HIV transmission among injection drug users and the potential for effective interventions. J Urban Health. 2004;81:655\u2013660.","journal-title":"J Urban Health"},{"key":"9312_CR13","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1360-0443.2005.01089.x","volume":"100","author":"MT Brugal","year":"2005","unstructured":"Brugal MT, Domingo-Salvany A, Puig R, Barrio G, Garcia de Olalla P, de la Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction. 2005;100:981\u2013989.","journal-title":"Addiction"},{"key":"9312_CR14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1440-1746.2006.04358.x","volume":"22","author":"J Reimer","year":"2007","unstructured":"Reimer J, Lorenzen J, Baetz B, et al. Multiple viral hepatitis in injection drug users and associated risk factors. J Gastroenterol Hepatol. 2007;22:80\u201385.","journal-title":"J Gastroenterol Hepatol"},{"key":"9312_CR15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00126334-200210010-00015","volume":"31","author":"DR Gibson","year":"2002","unstructured":"Gibson DR, Brand R, Anderson K, Kahn JG, Perales D, Guydish J. Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. J Acquir Immune Defic Syndr. 2002;31:237\u2013242.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9312_CR16","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1081\/JA-200042287","volume":"40","author":"E Wood","year":"2005","unstructured":"Wood E, Li K, Palepu A, et al. Sociodemographic disparities in access to addiction treatment among a cohort of Vancouver injection drug users. Subst Use Misuse. 2005;40:1153\u201367.","journal-title":"Subst Use Misuse"},{"key":"9312_CR17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1360-0443.2004.00963.x","volume":"100","author":"LE Sullivan","year":"2005","unstructured":"Sullivan LE, Metzger DS, Fudala PJ, Fiellin DA. Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. Addiction. 2005;100:150\u2013158.","journal-title":"Addiction"},{"key":"9312_CR18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/10550490601184472","volume":"16","author":"CA Jong De","year":"2007","unstructured":"De Jong CA, Roozen HG, van Rossum LG, Krabbe PF, Kerkhof AJ. High abstinence rates in heroin addicts by a new comprehensive treatment approach. Am J Addict. 2007;16:124\u2013130.","journal-title":"Am J Addict"},{"key":"9312_CR19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","volume":"28","author":"L Amato","year":"2005","unstructured":"Amato L, Davoli M, A Perucci C, Ferri M, Faggiano F, P Mattick R. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat. 2005;28:321\u2013329.","journal-title":"J Subst Abuse Treat"},{"key":"9312_CR20","doi-asserted-by":"crossref","unstructured":"Mattick R, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2008;CD002207.","DOI":"10.1002\/14651858.CD002207.pub3"},{"key":"9312_CR21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s11414-007-9074-2","volume":"34","author":"JA Trafton","year":"2007","unstructured":"Trafton JA, Humphreys K, Harris AH, Oliva E. Consistent adherence to guidelines improves opioid dependent patients\u2019 first year outcomes. J Behav Health Serv Res. 2007;34:260\u2013271.","journal-title":"J Behav Health Serv Res"},{"key":"9312_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0376-8716(01)00199-5","volume":"66","author":"MF Goldstein","year":"2002","unstructured":"Goldstein MF, Deren S, Kang SY, Des Jarlais DC, Magura S. Evaluation of an alternative program for MMTP drop-outs: impact on treatment re-entry. Drug Alcohol Depend. 2002;66:181\u2013187.","journal-title":"Drug Alcohol Depend"},{"key":"9312_CR23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.drugalcdep.2005.01.013","volume":"79","author":"F Termorshuizen","year":"2005","unstructured":"Termorshuizen F, Krol A, Prins M, Geskus R, van den Brink W, van Ameijden EJ. Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam Cohort Study among drug users. Drug Alcohol Depend. 2005;79:231\u2013240.","journal-title":"Drug Alcohol Depend"},{"key":"9312_CR24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0376-8716(98)00132-X","volume":"53","author":"D Best","year":"1999","unstructured":"Best D, Gossop M, Stewart D, Marsden J, Lehmann P, Strang J. Continued heroin use during methadone treatment: relationships between frequency of use and reasons reported for heroin use. Drug Alcohol Depend. 1999;53:191\u2013195.","journal-title":"Drug Alcohol Depend"},{"key":"9312_CR25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/BF03405776","volume":"95","author":"JF Anderson","year":"2004","unstructured":"Anderson JF, Warren LD. Client retention in the British Columbia Methadone Program, 1996\u20131999. Can J Public Health. 2004;95:104\u2013109.","journal-title":"Can J Public Health"},{"key":"9312_CR26","volume-title":"Methadone maintenance treatment: translating research into policy","author":"National Institute on Drug Abuse","year":"1995","unstructured":"National Institute on Drug Abuse. Methadone maintenance treatment: translating research into policy. Washington, DC: NIDA Research Monograph; 1995."},{"issue":"5","key":"9312_CR27","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.addbeh.2004.09.004","volume":"30","author":"CJ Strike","year":"2005","unstructured":"Strike CJ, Gnam W, Urbanoski K, Fischer B, Marsh DC, Millson M. Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence. Addictive Behaviors. 2005;30(5):1025\u20131028.","journal-title":"Addictive Behaviors"},{"key":"9312_CR28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF03405382","volume":"98","author":"M Perreault","year":"2007","unstructured":"Perreault M, Heroux MC, White ND, Lauzon P, Mercier C, Rousseau M. [Treatment retention and evolution of clientele in a low threshold methadone substitution treatment program in Montreal]. Can J Public Health. 2007;98:33\u201336.","journal-title":"Can J Public Health"},{"key":"9312_CR29","volume-title":"Reviewing current practice in drug substitution treatment in the European Union","author":"M Farrell","year":"2000","unstructured":"Farrell M, Howes S, Verster AD, Davoli M. Reviewing current practice in drug substitution treatment in the European Union. Louxembourg: EMCDDA; 2000."},{"key":"9312_CR30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.drugalcdep.2008.01.015","volume":"95","author":"HU Wittchen","year":"2008","unstructured":"Wittchen HU, Apelt SM, Soyka M, et al. Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients. Drug Alcohol Depend. 2008;95:245\u201357.","journal-title":"Drug Alcohol Depend"},{"key":"9312_CR31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.317.7150.13","volume":"317","author":"TV Perneger","year":"1998","unstructured":"Perneger TV, Giner F, del Rio M, Mino A. Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ. 1998;317:13\u201318.","journal-title":"BMJ"},{"key":"9312_CR32","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1360-0443.2008.02185.x","volume":"103","author":"U Verthein","year":"2008","unstructured":"Verthein U, Bonorden-Kleij K, Degkwitz P, et al. Long-term effects of heroin-assisted treatment in Germany. Addiction.. 2008;103:960\u2013966, discussion 967\u20138.","journal-title":"Addiction."},{"key":"9312_CR33","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(01)06529-1","volume":"358","author":"J Rehm","year":"2001","unstructured":"Rehm J, Gschwend P, Steffen T, Gutzwiller F, Dobler-Mikola A, Uchtenhagen A. Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Lancet. 2001;358:1417\u20131423.","journal-title":"Lancet"},{"key":"9312_CR34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000068811","volume":"9","author":"F Guttinger","year":"2003","unstructured":"Guttinger F, Gschwend P, Schulte B, Rehm J, Uchtenhagen A. Evaluating long-term effects of heroin-assisted treatment: the results of a 6-year follow-up. Eur Addict Res. 2003;9:73\u201379.","journal-title":"Eur Addict Res"},{"key":"9312_CR35","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/bmj.327.7410.310","volume":"327","author":"W Brink van den","year":"2003","unstructured":"van den Brink W, Hendriks VM, Blanken P, Koeter MW, van Zwieten BJ, van Ree JM. Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ. 2003;327:310.","journal-title":"BMJ"},{"key":"9312_CR36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jsat.2006.04.007","volume":"31","author":"JC March","year":"2006","unstructured":"March JC, Oviedo-Joekes E, Perea-Milla E, Carrasco F. Controlled trial of prescribed heroin in the treatment of opioid addiction. J Subst Abuse Treat. 2006;31:203\u2013211.","journal-title":"J Subst Abuse Treat"},{"key":"9312_CR37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1192\/bjp.bp.106.026112","volume":"191","author":"C Haasen","year":"2007","unstructured":"Haasen C, Verthein U, Degkwitz P, Berger J, Krausz M, Naber D. Heroin-assisted treatment for opioid dependence: Randomised controlled trial. Br J Psychiatry. 2007;191:55\u201362.","journal-title":"Br J Psychiatry"},{"key":"9312_CR38","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000259089","volume":"1","author":"A Kokkevi","year":"1995","unstructured":"Kokkevi A, Hartgers C. EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur Addict Res. 1995;1:208\u2013210.","journal-title":"Eur Addict Res"},{"key":"9312_CR39","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0895-4356(98)00103-6","volume":"51","author":"J Brazier","year":"1998","unstructured":"Brazier J, Usherwood T, Harper R, Thomas K. Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol. 1998;51:1115\u20131128.","journal-title":"J Clin Epidemiol"},{"key":"9312_CR40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.drugalcdep.2005.08.012","volume":"82","author":"BP Zanden van der","year":"2006","unstructured":"van der Zanden BP, Dijkgraaf MG, Blanken P, de Borgie CA, van Ree JM, van den Brink W. Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population. Drug Alcohol Depend. 2006;82:111\u2013118.","journal-title":"Drug Alcohol Depend"},{"key":"9312_CR41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF00783424","volume":"31","author":"A Janca","year":"1996","unstructured":"Janca A, Kastrup M, Katschnig H, Lopez-Ibor JJ Jr, Mezzich JE, Sartorius N. The World Health Organization Short Disability Assessment Schedule (WHO DAS-S): a tool for the assessment of difficulties in selected areas of functioning of patients with mental disorders. Soc Psychiatry Psychiatr Epidemiol. 1996;31:349\u2013354.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"9312_CR42","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1046\/j.1360-0443.1998.9312185711.x","volume":"93","author":"J Marsden","year":"1998","unstructured":"Marsden J, Gossop M, Stewart D, et al. The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction. 1998;93:1857\u20131867.","journal-title":"Addiction"},{"key":"9312_CR43","volume-title":"Medical co-prescription of heroin: Two randomized controlled trials","author":"W Brink van den","year":"2002","unstructured":"van den Brink W, Hendriks VM, Blanken P, Huijsman IA, van Ree JM. Medical co-prescription of heroin: Two randomized controlled trials. Netherlands: Central Committee on the Treatment of Heroin Addicts (CCBH); 2002."},{"key":"9312_CR44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/eurpub\/11.4.425","volume":"11","author":"T Steffen","year":"2001","unstructured":"Steffen T, Blattler R, Gutzwiller F, Zwahlen M. HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme. Eur J Public Health. 2001;11:425\u2013430.","journal-title":"Eur J Public Health"},{"key":"9312_CR45","volume-title":"Programa experimental de prescripci\u00f3n de estupefacientes en Andaluc\u00eda PEPSA. Informe final. Granada, Espa\u0144a.: Consejer\u00eda para la Igualdad y Bienestar Social, Gobierno de Andaluc\u00eda (Espa\u0144a). Comisionado para la Droga","author":"JC March","year":"2005","unstructured":"March JC, Oviedo-Joekes E, Perea-Milla E, Carrasco F, PEPSA Team. Programa experimental de prescripci\u00f3n de estupefacientes en Andaluc\u00eda PEPSA. Informe final. Granada, Espa\u0144a.: Consejer\u00eda para la Igualdad y Bienestar Social, Gobierno de Andaluc\u00eda (Espa\u0144a). Comisionado para la Droga. C\u00f3digo: PEPSA-CAS-CD 2001l; 2005."},{"key":"9312_CR46","volume-title":"The German model project for heroin assisted treatment of opioid dependent patients. A multicentric, randomized, controlled treatment study","author":"C Haasen","year":"2006","unstructured":"Haasen C, Vertheim U, Degkwitz P, et al. The German model project for heroin assisted treatment of opioid dependent patients. A multicentric, randomized, controlled treatment study. Germany: Centre for Interdisciplinary Addiction Research of Hamburg University (ZIS); 2006."},{"key":"9312_CR47","unstructured":"SPSS I. SPSS 15.0.0 for windows. Chicago, Illinois: 2006."},{"key":"9312_CR48","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/jurban\/jti076","volume":"82","author":"K Shannon","year":"2005","unstructured":"Shannon K, Bright V, Duddy J, Tyndall MW. Access and utilization of HIV treatment and services among women sex workers in Vancouver\u2019s Downtown Eastside. J Urban Health. 2005;82:488\u2013497.","journal-title":"J Urban Health"},{"key":"9312_CR49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drugpo.2005.08.004","volume":"17","author":"D Small","year":"2006","unstructured":"Small D, Palepu A, Tyndall MW. The Establishment of North America\u2019s First State Sanctioned Supervised Injection Facility: a Case Study in Culture Change. Int J Drug Policy. 2006;17:73\u201382.","journal-title":"Int J Drug Policy"},{"key":"9312_CR50","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.healthplace.2006.05.005","volume":"13","author":"B Maas","year":"2007","unstructured":"Maas B, Fairbairn N, Kerr T, Li K, Montaner JS, Wood E. Neighborhood and HIV infection among IDU: place of residence independently predicts HIV infection among a cohort of injection drug users. Health Place. 2007;13:432\u2013439.","journal-title":"Health Place"},{"issue":"Suppl 1","key":"9312_CR51","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/00042560-199802001-00011","volume":"18","author":"RS Remis","year":"1998","unstructured":"Remis RS, Bruneau J, Hankins CA. Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal? J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(Suppl 1):S57\u2013S59.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"9312_CR52","doi-asserted-by":"crossref","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2003;CD002209.","DOI":"10.1002\/14651858.CD002209"},{"key":"9312_CR53","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.drugalcdep.2005.05.002","volume":"80","author":"T Kerr","year":"2005","unstructured":"Kerr T, Marsh D, Li K, Montaner J, Wood E. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver. Drug Alcohol Depend. 2005;80:329\u2013335.","journal-title":"Drug Alcohol Depend"},{"key":"9312_CR54","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/070674370605101002","volume":"51","author":"B Fischer","year":"2006","unstructured":"Fischer B, Cruz MF, Rehm J. Illicit opioid use and its key characteristics: a select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN). Can J Psychiatry. 2006;51:624\u2013634.","journal-title":"Can J Psychiatry"},{"key":"9312_CR55","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1360-0443.2004.00713.x","volume":"99","author":"J Bruneau","year":"2004","unstructured":"Bruneau J, Brogly SB, Tyndall MW, Lamothe F, Franco EL. Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: the interface with social factors and service utilization. Addiction. 2004;99:727\u2013737.","journal-title":"Addiction"},{"key":"9312_CR56","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF03405066","volume":"94","author":"M Perreault","year":"2003","unstructured":"Perreault M, Rousseau M, Mercier C, Lauzon P, Gagnon C, Cote P. [Accessibility to methadone substitution treatment: the role of a low-threshold program]. Can J Public Health. 2003;94:197\u2013200.","journal-title":"Can J Public Health"},{"issue":"Suppl 1","key":"9312_CR57","first-page":"S135","volume":"117","author":"S Galea","year":"2002","unstructured":"Galea S, Vlahov D. Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Rep. 2002;117(Suppl 1):S135\u2013S145.","journal-title":"Public Health Rep"},{"key":"9312_CR58","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1047-2797(01)00284-8","volume":"12","author":"JB Vangeest","year":"2002","unstructured":"Vangeest JB, Johnson TP. Substance abuse and homelessness: direct or indirect effects? Ann Epidemiol. 2002;12:455\u2013461.","journal-title":"Ann Epidemiol"},{"key":"9312_CR59","first-page":"261","volume":"34","author":"AJ Strehlow","year":"1999","unstructured":"Strehlow AJ, Amos-Jones T. The homeless as a vulnerable population. Nurs Clin North Am. 1999;34:261\u2013274.","journal-title":"Nurs Clin North Am"},{"key":"9312_CR60","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1365-2524.2002.00357.x","volume":"10","author":"J Neale","year":"2002","unstructured":"Neale J, Kennedy C. Good practice towards homeless drug users: research evidence from Scotland. Health Soc Care Community. 2002;10:196\u2013205.","journal-title":"Health Soc Care Community"},{"key":"9312_CR61","first-page":"404","volume":"105","author":"MA Winkleby","year":"1990","unstructured":"Winkleby MA. Comparison of risk factors for ill health in a sample of homeless and nonhomeless poor. Public Health Rep. 1990;105:404\u2013410.","journal-title":"Public Health Rep"},{"key":"9312_CR62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000088581","volume":"12","author":"JC March","year":"2006","unstructured":"March JC, Oviedo-Joekes E, Romero M. Drugs and social exclusion in ten European cities. Eur Addict Res. 2006;12:33\u201341.","journal-title":"Eur Addict Res"},{"key":"9312_CR63","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1081\/JA-120017376","volume":"38","author":"M Coumans","year":"2003","unstructured":"Coumans M, Spreen M. Drug use and the role of homelessness in the process of marginalization. Subst Use Misuse. 2003;38:311\u2013338.","journal-title":"Subst Use Misuse"},{"key":"9312_CR64","first-page":"759","volume":"169","author":"T Kerr","year":"2003","unstructured":"Kerr T, Wood E, Small D, Palepu A, Tyndall MW. Potential use of safer injecting facilities among injection drug users in Vancouver\u2019s Downtown Eastside. CMAJ. 2003;169:759\u2013763.","journal-title":"CMAJ"},{"key":"9312_CR65","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Annual report 2007: the state of the drugs problem in Europe. 2007. Luxembourg: Office for Official Publications of the European Communities."},{"key":"9312_CR66","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000079835","volume":"10","author":"M Prinzleve","year":"2004","unstructured":"Prinzleve M, Haasen C, Zurhold H, et al. Cocaine use in Europe\u2014a multi-centre study: patterns of use in different groups. Eur Addict Res. 2004;10:147\u2013155.","journal-title":"Eur Addict Res"},{"key":"9312_CR67","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1037\/1064-1297.13.4.303","volume":"13","author":"F Leri","year":"2005","unstructured":"Leri F, Stewart J, Fischer B, et al. Patterns of opioid and cocaine co-use: a descriptive study in a Canadian sample of untreated opioid-dependent individuals. Exp Clin Psychopharmacol. 2005;13:303\u2013310.","journal-title":"Exp Clin Psychopharmacol"},{"key":"9312_CR68","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0376-8716(97)00049-5","volume":"46","author":"AI Alterman","year":"1997","unstructured":"Alterman AI, Kampman K, Boardman CR, et al. A cocaine-positive baseline urine predicts outpatient treatment attrition and failure to attain initial abstinence. Drug Alcohol Depend. 1997;46:79\u201385.","journal-title":"Drug Alcohol Depend"},{"key":"9312_CR69","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.drugalcdep.2007.11.021","volume":"94","author":"VA Gruber","year":"2008","unstructured":"Gruber VA, Delucchi KL, Kielstein A, Batki SL. A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification. Drug Alcohol Depend. 2008;94:199\u2013206.","journal-title":"Drug Alcohol Depend"},{"key":"9312_CR70","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1081\/JA-120016225","volume":"37","author":"S Magura","year":"2002","unstructured":"Magura S, Rosenblum A, Fong C, Villano C, Richman B. Treating cocaine-using methadone patients: predictors of outcomes in a psychosocial clinical trial. Subst Use Misuse. 2002;37:1927\u201355.","journal-title":"Subst Use Misuse"},{"key":"9312_CR71","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1176\/appi.ps.52.9.1223","volume":"52","author":"GW Joe","year":"2001","unstructured":"Joe GW, Simpson DD, Dansereau DF, Rowan-Szal GA. Relationships between counseling rapport and drug abuse treatment outcomes. Psychiatr Serv. 2001;52:1223\u20131229.","journal-title":"Psychiatr Serv"},{"key":"9312_CR72","first-page":"393","volume":"100","author":"F Kamal","year":"2007","unstructured":"Kamal F, Flavin S, Campbell F, Behan C, Fagan J, Smyth R. Factors affecting the outcome of methadone maintenance treatment in opiate dependence. Ir Med J. 2007;100:393\u2013397.","journal-title":"Ir Med J"},{"key":"9312_CR73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/00952999709001685","volume":"23","author":"CE Grella","year":"1997","unstructured":"Grella CE, Anglin MD, Wugalter SE. Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance treatment. Am J Drug Alcohol Abuse. 1997;23:15\u201342.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"9312_CR74","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1037\/0022-006X.75.5.765","volume":"75","author":"UE Ghitza","year":"2007","unstructured":"Ghitza UE, Epstein DH, Schmittner J, Vahabzadeh M, Lin JL, Preston KL. Randomized trial of prize-based reinforcement density for simultaneous abstinence from cocaine and heroin. J Consult Clin Psychol. 2007;75:765\u2013774.","journal-title":"J Consult Clin Psychol"},{"key":"9312_CR75","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF01318402","volume":"47","author":"R Blattler","year":"2002","unstructured":"Blattler R, Dobler-Mikola A, Steffen T, Uchtenhagen A. Decreasing intravenous cocaine use in opiate users treated with prescribed heroin. Soz Praventivmed. 2002;47:24\u201332.","journal-title":"Soz Praventivmed"}],"container-title":["Journal of Urban Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11524-008-9312-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11524-008-9312-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11524-008-9312-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T20:37:46Z","timestamp":1588883866000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11524-008-9312-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,29]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["9312"],"URL":"https:\/\/doi.org\/10.1007\/s11524-008-9312-9","relation":{},"ISSN":["1099-3460","1468-2869"],"issn-type":[{"value":"1099-3460","type":"print"},{"value":"1468-2869","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,29]]}}}